Browse Drug Recalls
989 FDA drug safety recalls.
FDA Drug Recall Enforcement Database
Browse 989 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.
Drug Safety Recalls
Browse 989 FDA drug recalls in TN.
| Date | Product | Reason | Class | Firm |
|---|---|---|---|---|
| Jun 2, 2015 | Tri-Mix ST9C (30 mg/2 mg/120 mcg) Injectable, The Compounding Pharmacy of Ame... | Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting pr... | Class II | The Compounding Pharmacy of America |
| Jun 2, 2015 | Morphine 50 mg/ml + Fentanyl 10,000 mcg/ml + Bupivacaine 25 mg/ml, Solution, ... | Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting pr... | Class II | The Compounding Pharmacy of America |
| Jun 2, 2015 | Bupivacaine 40 mg/ml +Baclofen 130 mcg/ml Intrathecal Solution, Sterile-Prese... | Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting pr... | Class II | The Compounding Pharmacy of America |
| Jun 2, 2015 | Estradiol Valerate 20 mg/ml Injectable ml Multi-Dose Vial, Sterile, Room Temp... | Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting pr... | Class II | The Compounding Pharmacy of America |
| Jun 2, 2015 | Hydromorphone 65 mg/ml Solution, Sterile-Preservative Free, The Compounding P... | Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting pr... | Class II | The Compounding Pharmacy of America |
| Jun 2, 2015 | Methylcobalamin 4,000 mcg/ml Injectable, Multi-Dose Vial, Sterile, Refrigerat... | Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting pr... | Class II | The Compounding Pharmacy of America |
| Jun 2, 2015 | MEGA-BURN* Injection, Multi-Dose Vial, Sterile, Room Temperature, The Compou... | Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting pr... | Class II | The Compounding Pharmacy of America |
| Jun 2, 2015 | Testosterone 200 mg, Sterile Pellet, The Compounding Pharmacy of America, Kno... | Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting pr... | Class II | The Compounding Pharmacy of America |
| Jun 2, 2015 | Testosterone USP (10 AQUEOUS) 100 mg/ml Injection, Multi-Dose Vial, Sterile, ... | Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting pr... | Class II | The Compounding Pharmacy of America |
| Jun 2, 2015 | Estradiol 15 mg, Sterile Pellet, The Compounding Pharmacy of America, Knoxvil... | Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting pr... | Class II | The Compounding Pharmacy of America |
| Jun 2, 2015 | Bi-Mix #1 (17.365 mg/0.59 mg) Injectable, Sterile, Keep Frozen, The Compoundi... | Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting pr... | Class II | The Compounding Pharmacy of America |
| Jun 2, 2015 | Testosterone Cypionate 220 mg/ml Injection, Multi-Dose Vial, Sterile, Room Te... | Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting pr... | Class II | The Compounding Pharmacy of America |
| Jun 2, 2015 | Tri-Mix (10/0.174/16) Injectable, Sterile, Keep Frozen, The Compounding Pharm... | Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting pr... | Class II | The Compounding Pharmacy of America |
| Jun 2, 2015 | Morphine 40 mg/ml + Bupivacaine 8 mg/ml Solution, Sterile-Preservative Free, ... | Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting pr... | Class II | The Compounding Pharmacy of America |
| Jun 2, 2015 | Methylcobalamin 10,000 mcg/ml Injectable, Multi-Dose Vial, Sterile, Refrigera... | Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting pr... | Class II | The Compounding Pharmacy of America |
| Jun 2, 2015 | Mannitol 5% Injectable, Multi-Dose Vial, Sterile, Room Temperature, The Compo... | Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting pr... | Class II | The Compounding Pharmacy of America |
| Jun 2, 2015 | Hydromorphone 70 mg/ml Solution, Sterile-Preservative Free, The Compounding P... | Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting pr... | Class II | The Compounding Pharmacy of America |
| Jun 2, 2015 | Morphine 40 mg/ml + Fentanyl 2,000 mcg/ml Solution, Sterile-Preservative Free... | Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting pr... | Class II | The Compounding Pharmacy of America |
| Jun 2, 2015 | Testosterone Cypionate 150 mg/ml Injection Multi-Dose Vial, Sterile, Room Tem... | Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting pr... | Class II | The Compounding Pharmacy of America |
| Jun 2, 2015 | HCG 1,000 IU/ml + Methylcobalamin 1 mg/ml Injection, Multi-Dose Vial, Sterile... | Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting pr... | Class II | The Compounding Pharmacy of America |
| Jun 2, 2015 | Estradiol Cypionate 5mg/ml Injectable, ml Multi-Dose Vial, Sterile Room Tempe... | Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting pr... | Class II | The Compounding Pharmacy of America |
| Jun 2, 2015 | HCG 1,000 IU/ml Injection, Multi-Dose Vial, Sterile, Refrigerate The Compound... | Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting pr... | Class II | The Compounding Pharmacy of America |
| Jun 2, 2015 | Morphine 42 mg/ml + Bupivacaine 8 mg/ml Solution, Sterile-Preservative Free, ... | Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting pr... | Class II | The Compounding Pharmacy of America |
| Jun 2, 2015 | Testosterone 70 mg, Sterile Pellet, The Compounding Pharmacy of America, Knox... | Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting pr... | Class II | The Compounding Pharmacy of America |
| Jun 2, 2015 | Fentanyl 5,000 mcg/ml, + Bupivacaine 15 mg/ml Intrathecal Solution, Sterile -... | Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting pr... | Class II | The Compounding Pharmacy of America |
| Jun 2, 2015 | Fentanyl 500 mcg/ml Intrathecal Solution, Sterile - Preservative Free, The Co... | Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting pr... | Class II | The Compounding Pharmacy of America |
| Jun 2, 2015 | Pyridoxine Hydrochloride 100 mg/ml Injectable, Multi-Dose Vial, Sterile, Refr... | Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting pr... | Class II | The Compounding Pharmacy of America |
| Jun 2, 2015 | Lipovicine-Choline 100 mg/ml-Acorbic Acid 45 mg/ml Injectable, Multi-Dose Via... | Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting pr... | Class II | The Compounding Pharmacy of America |
| Jun 2, 2015 | Morphine 50 mg/ml Solution, Sterile-Preservative Free, The Compounding Pharma... | Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting pr... | Class II | The Compounding Pharmacy of America |
| Jun 2, 2015 | HCG 1,100 IU/ml Injection, Multi-Dose Vial, Sterile, Refrigerate, 30 DAY KIT,... | Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting pr... | Class II | The Compounding Pharmacy of America |
| Jun 2, 2015 | HCG 1,000 IU/ml + Hydroxocobalamin 1,000 mcg/ml Injection, Multi-Dose Vial, S... | Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting pr... | Class II | The Compounding Pharmacy of America |
| Jun 2, 2015 | Testosterone Cypionate 200 mg/ml Anastrazole 0.25 mg/ml Injection, Multi-Dose... | Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting pr... | Class II | The Compounding Pharmacy of America |
| Jun 2, 2015 | Fentanyl 100 mcg/ml +Clonidine 400 mcg/ml Intrathecal Solution, Sterile-Prese... | Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting pr... | Class II | The Compounding Pharmacy of America |
| Jun 2, 2015 | Fentanyl 7,000 mcg/ml + Bupivacaine 6 mg/ml + Clonidine 40 mcg/ml Intrathecal... | Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting pr... | Class II | The Compounding Pharmacy of America |
| Jun 2, 2015 | Hydromorphone 80 mg/ml + Clonidine 1,800 mcg/ml + Baclofen 730 mcg/ml Intrath... | Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting pr... | Class II | The Compounding Pharmacy of America |
| Jun 2, 2015 | Lipotropic Methyl B-12 Injection, Multi-Dose Vial, Sterile, Room Temperature,... | Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting pr... | Class II | The Compounding Pharmacy of America |
| Jun 2, 2015 | Sufentanil 45 mcg/ml + Bupivacaine 5 mg/ml Solution, Sterile=Preservative Fre... | Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting pr... | Class II | The Compounding Pharmacy of America |
| Jun 2, 2015 | Alprostadil 50 mcg/ml Injection, Sterile, Keep Frozen, The Compounding Pharma... | Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting pr... | Class II | The Compounding Pharmacy of America |
| Jun 2, 2015 | Cyanocobalamin 1,000 mcg/ml + B-Complex 100 mg/ml, ml, Multi-Dose Vial, Steri... | Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting pr... | Class II | The Compounding Pharmacy of America |
| Jun 2, 2015 | HCG 5,000 IU/ml + Methylcobalamin 500 mcg/ml Injection, Multi-Dose Vial, Ster... | Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting pr... | Class II | The Compounding Pharmacy of America |
| Jun 2, 2015 | Sodium Tetradecyl Sulfate 5% Injectable, Multi-Dose Vial, Sterile, Refrigerat... | Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting pr... | Class II | The Compounding Pharmacy of America |
| Jun 2, 2015 | Hydromorphone 10 mg/ml + Bupivacaine 10 mg/ml Solution, Sterile-Preservative ... | Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting pr... | Class II | The Compounding Pharmacy of America |
| Jun 2, 2015 | Betamethasone Sodium Phosphate (10 ml) 30 mg/ml Injectable, The Compounding P... | Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting pr... | Class II | The Compounding Pharmacy of America |
| Jun 2, 2015 | SUPER LIPO Injectable, Multi-Dose Vial, Sterile, Room Temperature, The Compou... | Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting pr... | Class II | The Compounding Pharmacy of America |
| Jun 2, 2015 | Tri-Mix SUPER (28 mg/0.9 mg/37 mcg) Injectable, Sterile Keep Frozen, The Comp... | Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting pr... | Class II | The Compounding Pharmacy of America |
| Jun 2, 2015 | Tri-Mix T-106 (30 mg/1 mg/25 mcg) Injectable,The Compounding Pharmacy of Amer... | Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting pr... | Class II | The Compounding Pharmacy of America |
| Jun 2, 2015 | HCG 5,000 IU/ml Injection, Multi-Dose Vial, Sterile, Refrigerate The Compound... | Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting pr... | Class II | The Compounding Pharmacy of America |
| Jun 2, 2015 | Baclofen 1,000 mcg/ml Intrathecal Solution, Sterile-Preservative Free, The Co... | Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting pr... | Class II | The Compounding Pharmacy of America |
| Jun 2, 2015 | Tri-Mix (30/2/20) (MFG) Injectable, The Compounding Pharmacy of America, Knox... | Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting pr... | Class II | The Compounding Pharmacy of America |
| Jun 2, 2015 | Ascorbic Acid 500 mg/ml Injectable Vial, Sterile Multi-Dose Vial, Refrigerate... | Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting pr... | Class II | The Compounding Pharmacy of America |
Frequently Asked Questions
When a drug safety issue is identified — through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks — the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.
The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.
Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.